PetMed Express (FRA:PQM) Cyclically Adjusted Revenue per Share: €12.43 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:PQM PetMed Express Inc FRA:PQM
60 GF Score
Price €1.66
GF Value €2.39
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is PetMed Express Cyclically Adjusted Revenue per Share?

PetMed Express FRA:PQM +2.16% 60 Cyclically Adjusted Revenue per Share is €12.43 as of Mar. 2026. GuruFocus rates FRA:PQM with a GF Score™ of 60/100 and a GF Value™ of €2.39 (Possible Value Trap). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

PetMed Express's adjusted revenue per share for the three months ended in Mar. 2026 was €1.761. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €12.43 for the trailing ten years ended in Mar. 2026.

During the past 12 months, PetMed Express's average Cyclically Adjusted Revenue Growth Rate was -1.50% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 0.10% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 2.10% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 3.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of PetMed Express was 15.20% per year. The lowest was 0.10% per year. And the median was 5.50% per year.

As of today (2026-07-22), PetMed Express's current stock price is €1.659. PetMed Express's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was €12.43. PetMed Express's Cyclically Adjusted PS Ratio of today is 0.13.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of PetMed Express was 4.46. The lowest was 0.10. And the median was 1.74.


PetMed Express  (FRA:PQM) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

PetMed Express's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=1.659/12.43
=0.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of PetMed Express was 4.46. The lowest was 0.10. And the median was 1.74.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


PetMed Express Cyclically Adjusted Revenue per Share Related Terms


PetMed Express Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for PetMed Express's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PetMed Express Cyclically Adjusted Revenue per Share Chart

PetMed Express Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.39 14.39 14.78 13.93 12.43

PetMed Express Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.93 12.72 12.55 13.26 12.43

FRA:PQM vs SHFH, BHIC, SCNX: Cyclically Adjusted Revenue per Share Comparison

For the Pharmaceutical Retailers subindustry, PetMed Express's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PetMed Express Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, PetMed Express's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where PetMed Express's Cyclically Adjusted PS Ratio falls into.


FRA:PQM
60GF Score
PetMed Express Inc FRA:PQM
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PetMed Express Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, PetMed Express's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=1.761/330.2130*330.2130
=1.761

Current CPI (Mar. 2026) = 330.2130.

PetMed Express Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 3.173 241.018 4.347
201609 2.658 241.428 3.635
201612 2.456 241.432 3.359
201703 2.890 243.801 3.914
201706 3.467 244.955 4.674
201709 2.739 246.819 3.664
201712 2.487 246.524 3.331
201803 2.674 249.554 3.538
201806 3.658 251.989 4.794
201809 2.982 252.439 3.901
201812 2.576 251.233 3.386
201903 2.787 254.202 3.620
201906 3.497 256.143 4.508
201909 3.179 256.759 4.088
201912 2.697 256.974 3.466
202003 3.360 258.115 4.299
202006 4.262 257.797 5.459
202009 3.178 260.280 4.032
202012 2.694 260.474 3.415
202103 2.750 264.877 3.428
202106 3.259 271.696 3.961
202109 2.785 274.310 3.353
202112 2.643 278.802 3.130
202203 2.896 287.504 3.326
202206 3.265 296.311 3.639
202209 3.247 296.808 3.612
202212 2.737 296.797 3.045
202303 2.452 301.836 2.683
202306 3.552 305.109 3.844
202309 3.201 307.789 3.434
202312 2.932 306.746 3.156
202403 2.679 312.332 2.832
202406 2.937 314.175 3.087
202409 2.498 315.301 2.616
202412 2.405 315.605 2.516
202503 2.275 319.799 2.349
202506 2.138 322.561 2.189
202509 1.809 324.800 1.839
202512 1.653 324.054 1.684
202603 1.761 330.213 1.761

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €12.43 mean?
PetMed Express (FRA:PQM) has a Cyclically Adjusted Revenue per Share of €12.43 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on PetMed Express and its competitors.
Is PetMed Express' Cyclically Adjusted Revenue per Share too high?
PetMed Express' current Cyclically Adjusted Revenue per Share is €12.43. Overall, PetMed Express has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does PetMed Express' Cyclically Adjusted Revenue per Share compare to SHFH and BHIC?
PetMed Express' Cyclically Adjusted Revenue per Share of €12.43 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on PetMed Express and its competitors. PetMed Express's current Cyclically Adjusted Revenue per Share is €12.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PetMed Express stock overvalued right now?
Based on GuruFocus' analysis, PetMed Express (FRA:PQM) is currently considered Possible Value Trap. The stock's GF Value™ is €2.39, compared to a current price of €1.66 — trading 30.6% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is €12.43. PetMed Express' overall GF Score™ is 60/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For PetMed Express (FRA:PQM), the current Cyclically Adjusted Revenue per Share is €12.43 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PetMed Express (FRA:PQM) Overvalued in 2026?

Based on GuruFocus' analysis, PetMed Express stock appears to be undervalued. The current stock price of €1.66 is trading 30.6% below its estimated GF Value™ of €2.39. GuruFocus considers PetMed Express to be Possible Value Trap.

Key valuation signals for FRA:PQM:

  • Cyclically Adjusted Revenue per Share: €12.43
  • GF Value™: €2.39 vs. price of €1.66 (30.6% below fair value)
  • GF Score™: 60/100 with 4 warning signs

No single metric tells the full story. See the FRA:PQM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PetMed Express Business Description

Other Exchanges PETS:USA
Address 420 South Congress Avenue, Suite 100, Delray Beach, FL, USA, 33445
PetMed Express Inc is a nationwide direct-to-consumer pet pharmacy and online provider of prescription and non-prescription medications, foods, supplements, supplies, and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile application, offering convenience, price, speed of delivery, and customer service. It provides access to branded pharmaceuticals, generic medications, compounded prescription medications, over-the-counter health and wellness products, prescription and non-prescription food, pharmacy fulfillment, and AutoShip capabilities. Its digital platform offers pet healthcare solutions for chronic conditions, including allergies, arthritis, anxiety, kidney-related conditions, and hyperthyroidism.
60GF Score

Get the complete analysis for FRA:PQM

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.66
Price
€2.39
GF Value